Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Author's Avatar
Jun 07, 2022

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules.